Search results for "Venous Thromboembolism"
Rivaroxaban after discharge may reduce thromboembolic risk in medically ill
An industry-funded trial that gave medical patients rivaroxaban for 45 days after hospital discharge found decreased risk for a composite end point of symptomatic venous thromboembolism, myocardial infarction, nonhemorrhagic stroke, and cardiovascular death compared to placebo.
https://acphospitalist.acponline.org/weekly/archives/2020/06/24/3.htm
24 Jun 2020
July 2007
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2007/07/
Latest inpatient COVID-19 research looks at plasma, intubation, delirium, VTE, and more
Recent studies showed that convalescent plasma didn't improve outcomes, a protocol reduced intubation rates, delirium was a common presentation among elderly patients, venous thromboembolism (VTE) was more common in the ICU, and racial disparities persisted after adjustment.
https://acphospitalist.acponline.org/weekly/archives/2020/11/25/2.htm
25 Nov 2020
October 2013
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2013/10/
Two studies offer insight on using age, d-dimer, algorithms for diagnosing PE
For patients with suspected pulmonary embolism (PE), a meta-analysis found that pretest probability-dependent d-dimer thresholds were the most efficient strategy, while a trial found that the YEARS rule with an age-adjusted d-dimer cutoff was noninferior to a conventional strategy.
https://acphospitalist.acponline.org/weekly/archives/2021/12/15/1.htm
15 Dec 2021
August 17, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/08/17/
Review finds 18% mortality in severe DOAC-related bleeding treated with reversal agent
A systematic review looked at 60 studies that evaluated four-factor prothrombin complex concentrates, idarucizumab, or andexanet for the treatment of severe or uncontrolled bleeding in patients on a direct oral anticoagulant (DOAC).
https://acphospitalist.acponline.org/weekly/archives/2021/06/16/4.htm
16 Jun 2021
January 2015
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2015/01/
Pandemic lessons, VTE prediction, and COVID-19 effects on other inpatients
One hospital reduced unnecessary labs during the pandemic, while another collected nine lessons to improve health care. Other recent studies looked at venous thromboembolism (VTE) in COVID-19 inpatients and mortality rates among patients hospitalized for other conditions during last year's surges.
https://acphospitalist.acponline.org/weekly/archives/2021/07/28/1.htm
28 Jul 2021
February 2019
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2019/02/